Qual é o preço para Aspire Biopharma Holdings, Inc. (ASBP)

O preço para Aspire Biopharma Holdings, Inc. (ASBP) é $7.37

Qual é a capitalização de mercado para Aspire Biopharma Holdings, Inc. (ASBP)

A capitalização de mercado para Aspire Biopharma Holdings, Inc. (ASBP) é $850.29K

Histórico de Preços de Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Ano	Desempenho
2026 (TTM)	27.39%
2025	-99.12%
2024	4.87%
2023	6.40%
2022	0.00%

Ano

Desempenho

2026 (TTM)

27.39%

2025

-99.12%

2024

4.87%

2023

6.40%

2022

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$506.92	29.88%	US
Argenx SE ARGX.US	$843.33	29.26%	NL
Lonza Group AG LONN.SW	$731.69	7.13%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$251.82	11.25%	BE

Empresa

Preço da ação

Variação 1a%

País